MCP compliance catalog

Every MCP tool in the SCOPE compliance index, grouped by server — risk posture, regulatory exposure, and the tools that warrant tighter governance.
303MCP servers
4476tools
Reset 303 of 303 servers
Ashby
17 tools · footprint 16
6 med 11 low
CData Connect AI
8 tools · footprint 16
1 critical 1 high 6 low
DataHub
24 tools · footprint 16
8 med 16 low
Google Compute Engine
25 tools · footprint 16
1 critical 6 med 18 low
Google Drive
7 tools · footprint 16
2 high 2 med 3 low
Guru
5 tools · footprint 16
3 med 2 low
HealthEx
15 tools · footprint 16
1 high 11 med 3 low HIPAA
Lumin PDF
7 tools · footprint 16
2 high 2 med 3 low
Microsoft OneDrive (Work IQ)
17 tools · footprint 16
1 high 4 med 12 low
Mintlify
17 tools · footprint 16
2 high 7 med 8 low
Sumble
25 tools · footprint 16
2 high 2 med 21 low
ThoughtSpot Spotter
12 tools · footprint 16
6 med 6 low
Coupler.io
4 tools · footprint 15
1 high 3 low
Digits
10 tools · footprint 15
5 med 5 low
Dovetail
9 tools · footprint 15
5 med 4 low
Gmail
10 tools · footprint 15
2 high 1 med 7 low
‹ PrevPage 9 of 19Next ›
AdisInsight
4 low · 4 tools · 0 SoD-flagged
regimes none

Tools needing tighter control (0 of 4)

None — every tool is low-risk, high-confidence, and outside PCI/HIPAA payload scope.
All other tools (4)
adisinsight.get_drug low conf mediumallow
Returns a full drug profile including development history, aggregate adverse-event data, organizations, and brand names from the Adis intelligence database.
adisinsight.get_trial low conf mediumallow
Returns a complete clinical-trial profile including investigators, study centres, compounds, indications, endpoints, and eligibility criteria from published trial intelligence.
adisinsight.search_drugs low conf mediumallow
Queries the Adis pharmaceutical database across drug name, therapeutic area, developer, mechanism, phase, and 60+ filters, returning commercial drug-intelligence results only.
adisinsight.search_trials low conf mediumallow
Searches clinical-trial records by condition, sponsor, compound, phase, status, and demographic criteria, exposing competitive trial-intelligence but no individual patient records.